Use App
New
Connect your Agent
Trending
News
Earnings
All
DIA
0.53%
SPY
0.39%
QQQ
0.18%
Trending
SOL
1.46%
ZEC
3.97%
DASH
34.01%
PATH
16.63%
LTC
5.86%
FCEL
1.91%
ICP
6.12%
BE
7.35%
TRUMP
1.04%
ALB
4.45%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
MDNAF
news
Exchange:
OTC
·
Updated 02:35 PM EDT
MDNAF News
News
all
press releases
Medicenna Therapeutics (MDNAF) Upgraded to Buy: Here's What You Should Know
Medicenna Therapeutics (MDNAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
1
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile